Home Other Building Blocks Lithium difluoro(oxalato)borate

Lithium difluoro(oxalato)borate

CAS No.:
409071-16-5
Catalog Number:
AG00353N
Molecular Formula:
C2BF2LiO4
Molecular Weight:
143.7678
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG00353N
Chemical Name:
Lithium difluoro(oxalato)borate
CAS Number:
409071-16-5
Molecular Formula:
C2BF2LiO4
Molecular Weight:
143.7678
MDL Number:
MFCD27952543
IUPAC Name:
lithium;2,2-difluoro-1,3-dioxa-2-boranuidacyclopentane-4,5-dione
InChI:
InChI=1S/C2BF2O4.Li/c4-3(5)8-1(6)2(7)9-3;/q-1;+1
InChI Key:
MEDDCIKGDMDORY-UHFFFAOYSA-N
SMILES:
F[B-]1(F)OC(=O)C(=O)O1.[Li+]
Properties
Complexity:
164  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
144.002g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
143.765g/mol
Monoisotopic Mass:
144.002g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
52.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Hepatitis C virus nucleotide inhibitors PSI-352938 and PSI-353661 exhibit a novel mechanism of resistance requiring multiple mutations within replicon RNA. Journal of virology 20111201
Synthesis of stable isotope labeled analogs of the anti-hepatitis C virus nucleotide prodrugs PSI-7977 and PSI-352938. Nucleosides, nucleotides & nucleic acids 20111101
Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methylguanosine. Antimicrobial agents and chemotherapy 20110601
Stereoselective synthesis of PSI-352938: a β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyl-3',5'-cyclic phosphate nucleotide prodrug for the treatment of HCV. The Journal of organic chemistry 20110520
Properties